ストックスクリーナーアプリを入手
27.62
1.18%
-0.33
アフターアワーズ：
27.45
-0.17
-0.62%
Avalyn Pharma Inc (AVLN) 最新ニュース
Avalyn Pharma (NASDAQ:AVLN) Shares Gap DownTime to Sell? - MarketBeat
Avalyn Pharma Inc. Revenue Breakdown – NASDAQ:AVLN - TradingView
AVLN|Avalyn Pharma Ord Shs (Proposed)|Price:27.950|Chg%:-1.780 - TradingKey
Adam H. Golden Net Worth (2026) - GuruFocus
Enterprise value to revenue forward of Avalyn Pharma Inc. – NASDAQ:AVLN - TradingView
Price to sales forward of Avalyn Pharma Inc. – NASDAQ:AVLN - TradingView
Price to book forward of Avalyn Pharma Inc. – NASDAQ:AVLN - TradingView
Avalyn Pharma Inc (AVLN:UW): Stock Price, Quote and News - BNN Bloomberg
Avalyn Pharma Inc. (NASDAQ:AVLN) Receives Average Rating of "Buy" from Analysts - MarketBeat
Avalyn Pharma (NASDAQ:AVLN) Shares Up 5.3%Here's Why - MarketBeat
Melissa Rhodes Net Worth (2026) - GuruFocus
Avalyn Pharma Inc.common stock (AVLN) Stock Price, News, Quote & History - FinancialContent
AVALYN PHARMA INC (AVLN) News Flow - Moomoo
Avalyn Pharma (AVLN) Short Interest & Short Float | Updated Jul 2026 - MarketBeat
Enterprise value to EBIT forward of Avalyn Pharma Inc. – NASDAQ:AVLN - TradingView
Enterprise value to EBITDA forward of Avalyn Pharma Inc. – NASDAQ:AVLN - TradingView
Price to earnings forward of Avalyn Pharma Inc. – NASDAQ:AVLN - TradingView
Avalyn Pharma Inc.(NasdaqGS: AVLN) added to Russell 2000 Index - marketscreener.com
Avalyn Pharma Inc Actuals & Estimates (NASDAQ:AVLN) - TradingView
Avalyn Pharma Inc.(NasdaqGS: AVLN) added to Russell 2000 Value Benchmark - marketscreener.com
Avalyn Pharma Inc.(NasdaqGS: AVLN) added to Russell 2000 Growth Benchmark - marketscreener.com
Avalyn Pharma Inc.(NasdaqGS: AVLN) added to Russell 3000E Growth Benchmark - marketscreener.com
AVLN Forecast — Price Target — Prediction for 2027 - TradingView
Avalyn Pharma Inc.(NasdaqGS: AVLN) added to Russell Small Cap Completeness Index - marketscreener.com
Avalyn Pharma Inc.(NasdaqGS: AVLN) added to Russell 2500 Index - marketscreener.com
Avalyn Pharma Inc. (AVLN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Avalyn Pharma (AVLN) Stock Chart and Price History 2026 - MarketBeat
Avalyn Pharma (AVLN) Stock Trends and Sentiment 2026 - MarketBeat
‘The window’s open’: At BIO, investors take stock of a growing class of biotech IPOs - BioPharma Dive
Avalyn Pharma Inc.(NasdaqGS: AVLN) added to S&P TMI Index - marketscreener.com
IPO Tracker 2026: Cardio biotech Kardigan binds off $400M upsized IPO - BioSpace
Avalyn Pharma (AVLN) Earnings Date and Reports 2026 - MarketBeat
Avalyn Pharma (AVLN) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Why is Avalyn Pharma stock surging today? By Investing.com - Investing.com UK
Avalyn Pharma stock rises on Phase 2b trial enrollment milestone By Investing.com - Investing.com Canada
Avalyn Pharma stock rises on Phase 2b trial enrollment milestone - Investing.com
Avalyn Pharma completes enrollment in pulmonary fibrosis trial - Investing.com
Avalyn Pharma completes enrollment in pulmonary fibrosis trial By Investing.com - Investing.com Australia
Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis - The Manila Times
Avalyn Pharma Ord Shs (Proposed) (AVLN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Avalyn Pharma Outlines Inhaled Fibrosis Push After IPO, With Pivotal Data Ahead - inkl
Morgan Stanley Maintains AVALYN PHARMA INC(AVLN.US) With Buy Rating, Maintains Target Price $53 - 富途牛牛
Avalyn Pharma Inc. 2026 Q1 Financial Report and Material Risks Overview - Minichart
Avalyn Pharma 1Q Loss $26.9M >AVLN - Moomoo
Press Release: Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights - Moomoo
AVLN SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus
Avalyn Pharma Inc. 1Q 2026: Net income $(26.9M), EPS $(21.83) — 10-Q Summary - TradingView
Avalyn: Q1 Earnings Snapshot - marketscreener.com
1.97%
0.83%
大文字化:
|
ボリューム (24 時間):